다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of Korean medical science : JKMS, v.26 no.10, 2011년, pp.1258 - 1264
Kim, Jieun (Department of Internal Medicine, Hanyang University College of Medicine, Guri, Korea.) , Pai, Hyunjoo (Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.) , Seo, Mi-ran (Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.) , Kang, Jung Oak (Department of Clinical Microbiology, Hanyang University College of Medicine, Guri, Korea.)
AI-Helper
In order to investigate the incidence, clinical and microbiologic characteristics of Clostridium difficile infection (CDI) in Korea, a prospective observational study was performed. From September 2008 through January 2010, all patients whose stool was tested for toxin assay A&B and/or C. difficile ...
1 Kelly CP LaMont JT Clostridium difficile: more difficult than ever N Engl J Med 2008 359 1932 1940 18971494
2 Pépin J Valiquette L Alary ME Villemure P Pelletier A Forget K Pépin K Chouinard D Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity CMAJ 2004 171 466 472 15337727
3 Lee YJ Choi MG Lim CH Jung WR Cho HS Sung HY Nam KW Chang JH Cho YK Park JM Kim SW Chung IS Change of Clostridium difficile colitis during recent 10 years in Korea Korean J Gastroenterol 2010 55 169 174 20357527
4 Shin BM Kuak EY Yoo HM Kim EC Lee K Kang JO Whang DH Shin JH Multicentre study of the prevalence of toxigenic Clostridium difficile in Korea: results of a retrospective study 2000-2005 J Med Microbiol 2008 57 697 701 18480325
5 McFarland LV Epidemiology, risk factors and treatments for antibiotic-associated diarrhea Dig Dis 1998 16 292 307 9892789
6 Gravel D Miller M Simor A Taylor G Gardam M McGeer A Hutchinson J Moore D Kelly S Boyd D Mulvey M Canadian Nosocomial Infection Surveillance Program Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study Clin Infect Dis 2009 48 568 576 19191641
7 O'Connor JR Johnson S Gerding DN Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain Gastroenterology 2009 136 1913 1924 19457419
8 The anatomical therapeutic chemical (ATC) and defined daily dosing (DDD) system index 2010 World Health Organisation accessed on 28 Oct 2010 Available at: http://www.whocc.no/
9 Zar FA Bakkanagari SR Moorthi KM Davis MB A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity Clin Infect Dis 2007 45 302 307 17599306
10 Louie T Miller M Donskey C Mullane K Goldstein EJ Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection Antimicrob Agents Chemother 2009 53 223 228 18955525
11 Barbut F Richard A Hamadi K Chomette V Burghoffer B Petit JC Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea J Clin Microbiol 2000 38 2386 2388 10835010
12 Aspinall ST Hutchinson DN New selective medium for isolating Clostridium difficile from faeces J Clin Pathol 1992 45 812 814 1401214
13 Persson S Torpdahl M Olsen KE New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection Clin Microbiol Infect 2008 14 1057 1064 19040478
14 Rupnik M Braun V Soehn F Janc M Hofstetter M Laufenberg-Feldmann R von Eichel-Streiber C Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile FEMS Microbiol Lett 1997 148 197 202 9084148
15 Tae CH Jung SA Song HJ Kim SE Choi HJ Lee M Hwang Y Kim H Lee K The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea J Korean Med Sci 2009 24 520 524 19543521
16 Lee JH Lee SY Kim YS Park SW Jo SY Ryu SH Lee JH Moon JS Whang DH Shin BM The incidence and clinical features of Clostridium difficile infection; single center study Korean J Gastroenterol 2010 55 175 182 20357528
17 Byun TJ Han DS Ahn SB Cho HS Kim TY Eun CS Jeon YC Sohn JH Kang JO Clinical characteristics and changing epidemiology of Clostridium difficile-associated disease (CDAD) Korean J Gastroenterol 2009 54 13 19 19696545
18 Jung KS Park JJ Chon YE Jung ES Lee HJ Jang HW Lee KJ Lee SH Moon CM Lee JH Shin JK Jeon SM Hong SP Kim TI Kim WH Cheon JH Risk factors for treatment failure and recurrence after metronidazole treatment for Clostridium difficile-associated diarrhea Gut Liver 2010 4 332 337 20981209
19 Cheong HS Kim JK Kwon KT Ryu SY Heo ST Ko KS Oh WS Peck KR Lee NY Song JH Therapeutic efficacy of metronidazole for patients with Clostridium difficile-associated diarrhea Korean J Med 2007 72 639 646
20 Belmares J Johnson S Parada JP Olson MM Clabots CR Bettin KM Peterson LR Gerding DN Molecular epidemiology of Clostridium difficile over the course of 10 years in a tertiary care hospital Clin Infect Dis 2009 49 1141 1147 19780659
21 Barbut F Gariazzo B Bonné L Lalande V Burghoffer B Luiuz R Petit JC Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004 Infect Control Hosp Epidemiol 2007 28 131 139 17265393
22 Riggs MM Sethi AK Zabarsky TF Eckstein EC Jump RL Donskey CJ Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents Clin Infect Dis 2007 45 992 998 17879913
23 Kyne L Warny M Qamar A Kelly CP Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A N Engl J Med 2000 342 390 397 10666429
24 Kim H Jeong SH Roh KH Hong SG Kim JW Shin MG Kim MN Shin HB Uh Y Lee H Lee K Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea Korean J Lab Med 2010 30 491 497 20890081
25 Kim H Riley TV Kim M Kim CK Yong D Lee K Chong Y Park JW Increasing prevalence of toxin A-negative, toxin B-positive isolates of Clostridium difficile in Korea: impact on laboratory diagnosis J Clin Microbiol 2008 46 1116 1117 18199783
26 Iwashima Y Nakamura A Kato H Wakimoto Y Wakiyama N Kaji C Ueda R A retrospective study of the epidemiology of Clostridium difficile infection at a University Hospital in Japan: genotypic features of the isolates and clinical characteristics of the patients J Infect Chemother 2010 16 329 333 20449624
27 Huang H Wu S Wang M Zhang Y Fang H Palmgren AC Weintraub A Nord CE Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes Int J Antimicrob Agents 2009 33 339 342 19097757
28 Elliott B Squire MM Thean S Chang BJ Brazier JS Rupnik M Riley TV New types of toxin A-negative, toxin B-positive strains among clinical isolates of Clostridium difficile in Australia J Med Microbiol 2011 60 1108 1111 21393460
29 Huang H Fang H Weintraub A Nord CE Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm Clin Microbiol Infect 2009 15 1170 1173 19624517
30 Pépin J Saheb N Coulombe MA Alary ME Corriveau MP Authier S Leblanc M Rivard G Bettez M Primeau V Nguyen M Jacob CE Lanthier L Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec Clin Infect Dis 2005 41 1254 1260 16206099
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.